Table 1.: Correlation of RKIP Expression to Clinical-Pathologic Features of Non-Small Cell Lung Cancer
| Item |
Cases |
RKIP |
P |
| Weak |
Moderate |
Strong Positive |
| Age (Years) |
| >60 |
84 |
14(16.7%) |
29(34.5%) |
41(48.8%) |
0.986 |
| <60 |
75 |
13(17.3%) |
25(33.4%) |
37(49.3%) |
|
| Sex |
| Male |
95 |
16(16.8%) |
32(33.7%) |
47(49.5%) |
0.992 |
| Female |
64 |
11(17.2%) |
22(34.4%) |
31(48.4%) |
|
| Histopathology |
| Squamous cell carcinoma |
102 |
16(15.7%) |
38(37.3%) |
48(47.0%) |
0.491 |
| Adenocarcinoma |
57 |
11(19.3%) |
16(28.1%) |
30(52.6%) |
|
| TNM Stage |
| I |
30 |
3(10.0%) |
4(13.3%) |
23(76.7%) |
0.002 |
| II |
67 |
11(16.4%) |
21(31.3%) |
35(52.2%) |
|
| III |
62 |
13(21.0%) |
29(46.8%) |
20(32.3%) |
|
| Tumor Size |
| ≤3cm |
42 |
8(19.0%) |
14(33.3%) |
20(47.6%) |
0.917 |
| >3cm |
117 |
19(16.2%) |
40(34.2%) |
58(49.6%) |
|
| Lymph Node Involvement |
| N0 |
30 |
2(6.7%) |
4(13.3%) |
24(80.0%) |
<0.01 |
| N1 |
78 |
12(15.4%) |
26(33.3%) |
40(51.3%) |
|
| N2 |
51 |
13(25.5%) |
24(47.1%) |
14(27.5%) |
|